Quest Diagnostics Aktie
WKN: 904533 / ISIN: US74834L1008
|
22.10.2026 12:53:43
|
Quest Diagnostics Announces Increase In Q3 Income
(RTTNews) - Quest Diagnostics (DGX) reported a profit for its third quarter that Increases, from last year
The company's bottom line came in at $312 million, or $2.78 per share. This compares with $245 million, or $2.16 per share, last year.
Excluding items, Quest Diagnostics reported adjusted earnings of $338 million or $3.00 per share for the period.
The company's revenue for the period rose 10.0% to $3.097 billion from $2.816 billion last year.
Quest Diagnostics earnings at a glance (GAAP) :
-Earnings: $312 Mln. vs. $245 Mln. last year. -EPS: $2.78 vs. $2.16 last year. -Revenue: $3.097 Bln vs. $2.816 Bln last year.
-Guidance: Full year EPS guidance: $ 11.25 To $ 11.35 Full year revenue guidance: $ 12.065 B To $ 12.105 B
Der finanzen.at Ratgeber für Aktien!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Quest Diagnostics Inc.
Analysen zu Quest Diagnostics Inc.
Aktien in diesem Artikel
| Quest Diagnostics Inc. | 217,20 | -0,28% |
|